Drug Pipeline

B007 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
3
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 2/3
3
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06447597 A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. Generalized Myasthenia Gravis Recruiting
NCT06454357 A Clinical Study of B007 in the Treatment of Pemphigus. Pemphigus Recruiting
NCT06470191 A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy. Primary Membranous Nephropathy Recruiting
Phase 1
NCT05668403 A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20)… Primary Membranous Nephropathy Recruiting
Sponsors Running B007 Trials
Disease Areas
Get alerts when B007 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free